BPCA and PREA Reauthorization Act of 2012

Legislation and issues relating to: Provisions of the Patient Protection & Affordable Care Act (P.L. 111-148); Nurse Education, Expansion, and Development Act; Nursing provisions in potential job creation legislation; Negotiated Rulemaking on Designation of Medically Underserved and Health Professional Shortage Areas; Administration review of current regulations; Prevention and Public Health Fund; Definition of essential health benefits; Health information technology and electronic health records; HRSA nurse practitioner national sample survey; Draft legislation to reauthorize the Prescription Drug User Fee Act (PDUFA); Draft legislation on Congressional Budget Office scoring of preventive health services; Draft legislation on voluntary tandem licensing and credentialing for federal telemedicine services; Draft legislation on reauthorization of the National Quality Forum; H.R. 5/S. 218/S. 1099 - Help Efficient, Accessible, Low Cost, Timely Healthcare (HEALTH) Act; H.R. 5 - Protecting Access to Healthcare (PATH) Act; H.R. 451 - Healthcare Truth and Transparency Act of 2011; S. 248/H.R. 844 - Empowering States to Innovate Act; S. 174 - Healthy Lifestyles and Prevention Act; H.R. 10/S. 299/S. 1720/S. 1786 - Regulations From the Executive in Need of Scrutiny (REINS) Act; H.R. 1217 - to repeal the Prevention and Public Health Fund; H.R. 1683/S. 868 - State Flexibility Act; H.R. 2465 - Federal Workers' Compensation Modernization and Improvement Act; S. 261 - Federal Employees' Compensation Reform Act; H.R. 469 - Protecting Student Athletes from Concussions Act; S. 601/H.R. 1127 - Childrens Sports Athletic Equipment Safety Act; Concussion Treatment and Care Tools (ConTACT) Act; H.R. 3679 - National Nurse Act; H.R. 4274 - BPCA and PREA Reauthorization Act; S. 2289 - Better Pharmaceuticals and Devices for Children Act; H.R. 5651 - Food and Drug Administration Reform Act; H.R. 5842 - Restoring Access to Medication Act; S. 3187 - FDA Safety and Innovation Act S. 2474 - Health Equity and Accountability Act; S. 1789 - 21st Century Postal Service Act; H.R. 6482 - Preventive Health Savings Act; Supplemental Nutrition Assistance Program (SNAP) provisions of H.R. 6083, Federal Agriculture Reform and Risk Management (FARRM) Act, and S.3240, Agriculture Reform, Food, and Jobs Act; S. 1560 - Nursing Home Resident Pain Relief Act.

Client expense: Not reported · Firm income: $23,450

Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Justice, Dept of (DOJ), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE, White House Office

Legislation and issues relating to: Provisions of the Patient Protection & Affordable Care Act (P.L. 111-148); Nurse Education, Expansion, and Development Act; Nursing provisions in potential job creation legislation; Negotiated Rulemaking on Designation of Medically Underserved and Health Professional Shortage Areas; Administration review of current regulations; Prevention and Public Health Fund; Definition of essential health benefits; Health information technology and electronic health records; HRSA nurse practitioner national sample survey; Amendments to the Consumer Product Safety Improvement Act; Menu and Nutrition Labeling; Draft legislation to reauthorize the Prescription Drug User Fee Act (PDUFA); Draft legislation on Congressional Budget Office scoring of preventive health services; Draft legislation on voluntary tandem licensing and credentialing for federal telemedicine services; Draft legislation on reauthorization of the National Quality Forum; H.R. 5/S. 218/S. 1099 - Help Efficient, Accessible, Low Cost, Timely Healthcare (HEALTH) Act; H.R. 5 - Protecting Access to Healthcare (PATH) Act; H.R. 451 - Healthcare Truth and Transparency Act of 2011; S. 248/H.R. 844 - Empowering States to Innovate Act; S. 174 - Healthy Lifestyles and Prevention Act; H.R. 10/S. 299/S. 1720/S. 1786 - Regulations From the Executive in Need of Scrutiny (REINS) Act; H.R. 1217 - to repeal the Prevention and Public Health Fund; H.R. 1683/S. 868 - State Flexibility Act; H.R. 2465 - Federal Workers' Compensation Modernization and Improvement Act; S. 261 - Federal Employees' Compensation Reform Act; H.R. 469 - Protecting Student Athletes from Concussions Act; S. 601/H.R. 1127 - Childrens Sports Athletic Equipment Safety Act; Concussion Treatment and Care Tools (ConTACT) Act; S. 54 - Supporting Child Maltreatment Prevention Efforts in Community Health Centers Act; S. 55 - Nursing School Clinics Act; H.R. 157 - Health Care Safety Net Enhancement Act; H.R. 227 - Child Gun Safety and Gun Access Prevention Act; H.R. 338 - Protecting Our Kids' Medicine Act; H.R. 469 - Protecting Student Athletes from Concussions Act; H.R. 576 - Healthy Children Through School Nutrition Education Act; H.R. 713 - Keeping Families Together Act; H.R. 751 - Mental Health in Schools Act; H.R. 1214 - to repeal mandatory funding for school-based health center construction; S. 961 - Reconnecting Youth to Prevent Homelessness Act; S. 1165, Button Cell Battery Safety Act. H.R. 1852/S. 958 - Childrens Hospital GME Support Reauthorization Act; H.R. 115 - CHAMPVA Childrens Protection Act; H.R. 364 - Common Sense Health Reform Americans Actually Want Act; H.R. 614 - Post 9/11 G.I. Bill Dependent Coverage Improvement Act; H.R. 978 - Seniors Identity Protection Act; H.R. 989 - Voluntary State Discount Prescription Drug Plan Act; H.R. 1035/S. 1504 - Medicaid Coverage for Citizens of Freely Associated States Act; H.R. 2029/S. 1131 - Birth Defects Prevention, Risk Reduction, and Awareness Act; H.R. 2758/S. 1463 - Breastfeeding Promotion Act; H.R. 2229 - Student-to-School Nurse Ratio Improvement Act. H.R. 3679 - National Nurse Act; H.R. 4274 - BPCA and PREA Reauthorization Act; S. 2289 - Better Pharmaceuticals and Devices for Children Act; H.R. 5651 - Food and Drug Administration Reform Act; H.R. 5842 - Restoring Access to Medication Act; S. 3187 - FDA Safety and Innovation Act S. 2474 - Health Equity and Accountability Act; S. 1789 - 21st Century Postal Service Act; S. 847 - Safe Chemicals Act; H.R. 2405/S. 1855/H.R. 6672 - Pandemic and All-Hazards Preparedness Act (PAHPA) reauthorization; H.R. 2359 - Safe Cosmetics Act; H.R. 6482 - Preventive Health Savings Act; Supplemental Nutrition Assistance Program (SNAP) provisions of H.R. 6083, Federal Agriculture Reform and Risk Management (FARRM) Act, and S.3240, Agriculture Reform, Food, and Jobs Act; H.R. 5647/S. 3565 - Pregnant Workers Fairness Act.

Client expense: Not reported · Firm income: $23,450

Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Justice, Dept of (DOJ), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE, White House Office

S. 3187, FDA Safety and Innovation Act; H.R. 4274, Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act; H.R. 1513/S. 810, Great Apes Protection Act; Pharmaceutical Traceability Enhancement Code (RxTEC) Act and draft legislation on downstream supply chain safety/serialization.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues relating to health disparities, health care reform, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: S. 494 and H.R. 912, Colorectal Cancer Prevention, Early Detection & Treatment Act; H.R. 1213, Repeal mandatory funding provided to states in PPACA to establish American Health Benefit Exchanges; H.R. 1217, Repeal Prevention and Public Health Fund; H.R. 1740 and H.R. 5560, the Quality Cancer Care for Life Act of 2010; H.R.2941 and S.3493; H.R.3974, Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009; H.R.4662, the Lymphedema Diagnosis and Treatment Cost Savings Act of 2010; the implementation of P.L. 111-148, the Patient Proection and Affordable Care Act of 2010; S.1064, the Sun Act; S.965, the Family Act; H.R.2954, Health Equity and Accountability Act of 2011; and H.R.2077, the MLR Repeal Act; H.R.2245 and S.296 Preserving Access to Life-Saving Medications Act, issues related to the reauthorization of the prescription drug user fee, S.3187, the FDA Safety and Innovation Act and the House Companion legislation, and issues relating to the ongoing national shortage of cancer drugs, Amendment relating to S.1813, the Moving Ahead for Progress in the 21st Century Act, and H.R.4274, reauthorization of the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act. Issues relating to global health including S.2515, the Clean Cookstoves Support Act of 2012; H.R.6155 & S.3047, the Palliative Care and Hospice Education & Training Act; and H.R.6157, the Patient Centered Quality of Care Act.

Client expense: $810,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), White House Office

S. 319, Pharmaceutical Market Access and Drug Safety Act - Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 752, Lung Cancer Mortality Reduction Act of 2011 - Lobbied for passage of bill to reduce lung cancer mortality. NO BILL, Health Care Reform Implementation - Lobbied on implementation of provisions in the health care reform bill regarding biosimilars, the Independent Payment Advisory Board and the Annual Fee. S. 296 and H.R. 2245, Preserving Access to Life-Savings Medications Act - Lobbied to improve provisions in the drug shortage legislation. H.R. 1483, Drug Safety Enhancement Act of 2011 - Lobbied to pass meaningful drug safety legislation. S. 3187, the "Food and Drug Administration Safety and Innovation Act - Lobbied for passage of PDUFA legislation. S. 2113, Transforming the Regulatory Environment to Accelerate Access to Treatments - Lobbied to pass meaningful FDA reform legislation. S. 2236, Advancing Breakthrough Therapies for Patients Act of 2012 - Lobbied to pass meaningful FDA reform legislation. H.R. 4274, BCPA and PREA Reauthorization Act of 2012 - Lobbied for permanence of BCPA and PREA. H.R. 3497, MODERN Cures Act of 2011 - Lobbied for incentives for development of pharmacodiagnostics and dormant therapies. H.R. 3737, Unlocking Lifesaving Treatments for Rare-Diseases Act - Lobbied to pass meaningful FDA reform legislation. H.R. 4132, Faster Access to Specialized Treatments Act - Lobbied to pass meaningful FDA reform legislation. Labor, HHS Appropriations. Lobbied for increased access to HIV/AIDS drugs in the AIDS Drug Assistance Program. NO BILL, Supply chain draft legislation - Lobbied for passage of legisaltion to increase security of the drug distribution supply chain.

Client expense: $1,280,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE, Treasury, Dept of

P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample reporting provisions; S.3187 FDA Safety and Innovation Act; H.R. 4274 Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; Pharmaceutical Traceability Enhancement Code (Rx TEC) Act and draft legislation on downstream supply chain safety/serialization; H.R. 5973 FY2013 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (FDA funding); 340B; HR 1513 / S 810 Great Apes Protection Act

Client expense: $270,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE

Appropriations for Patient Protection and Affordable Care Act (ACA) Behavioral Health Information Technology Act (S. 539) (HR 6043) State Flexibility Act (HR 1683) The BPCA and PREA Reauthorization Act (HR 4274) Preserving Access to Life Saving Medication Act (S 296) (HR 2245) Drug Shortage Prevention Act (HR 3839) Department of Labor, Health and Human Services and Education Related Agencies Appropriations Act 2013 (S 3295) (HR 3070) Protect our Kids Act of 2012 (S 3705) (HR 6655)

Client expense: Not reported · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)

H.R. 1513 and S.810 - Great Ape Protection and Cost Savings Act, provisions related to pre-clinical testing H.R. 1930 and S. 1799 - Access to Appropriate Immunizations for Veterans Act of 2011, provisions related to extending VA performance measure to include all federally recommended vaccine H.R. 2245, S. 296 - Preserving Access to Life-Savings Medicines Act of 2011, provisions related to drug shortages H.R. 2405 and S. 1855 - Pandemic and All Hazards Preparedness Act, provisions relating to influenza vaccine innovative technologies H.R. 2529 and S. 1368 - Restoring Access to Medication Act, provisions relating to reimbursement of OTC drugs under flexible spending and health savings accounts H.R. 2674 - 340B Program Improvement Act, provisions related to the 340B program H.R. 4132 - FAST Act, provisions related to accelerated approval and other FDA matters H.R. 4156 amd S. 2281 - Expanding and Promoting Expertise in Rare Treatments Act of 2012, provisions related to strengthening the FDA's ability to seek advice from external experts regarding rare diseases H.R. 4223 and S. 1002 - Strengthening and Focusing Enforcement to Deter Organized Stealing and Enhance Safety Act (SAFE DOSES), provisions related to supply chain security H.R. 4274 - BPCA and PREA Reauthorization Act of 2012, Provisions related to amending title IV of the Public Health Service Act and title V of the Federal Food, Drug, and Cosmetic Act to permanently extend the provisions of the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act H.R. 5651 - Food and Drug Administration Reform Act of 2012, provisions related to user fee reauthorization and FDA reform H.R. 6190 - Asthma Inhalers Relief Act of 2012, provisions relating to the removal of Essential-Use Designation for epinephrine H.R. 6611 - Patients Access to Drugs in Shortage Act of 2012, provisions to promote public notification and provide incentives to reduce drug shortages S. 1584 - Drug Safety and Accountability Act of 2011, provisions related to drug safety S. 1699- Prescription Drug Cost Reduction Act, provisions related to 340B and drug rebates S. 1752 - Freedom to Breath Act of 2011, provisions relating to the removal of Essential-Use Designation for epinephrine S. 2113 - Transforming the Regulatory Environment to Accelerate Access to Treatments (TREAT) Act, provisions related to accelerated approval and other FDA matters S. 2236 - Advancing Breakthrough Therapies for Patients Act of 2012, provisions related to FDA regulation S. 2281 - Expanding and Promoting Expertise in Rare Treatments Act, provisions related to FDA regulation S. 2289 - The Better Pharmaceuticals and Devices for Children Act, provisions related to amending the Federal Food, Drug, and Cosmetic Act with respect to pediatric provisions S. 3187 - Food and Drug Administration Safety and Innovation Act of 2012, provisions related to user fee reauthorization and FDA reform PL 111-148, PL 111-152 - Patient Protection and Affordable Care Act, ACA implementation, Independent Payment Advisory Board (IPAB), comparative effectiveness, health information technology, disease prevention/wellness, sunshine and innovation provisions Federal Food, Drug, and Cosmetic Act, section related to FDA and regulation of nicotine replacement therapies Comparative effectiveness policy issues H.R. 6687, To amend the Internal Revenue Code of 1986 to include vaccines against seasonal influenza within the definition of taxable vaccines

Client expense: $1,370,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR), White House Office

H.R. 5651, S. 3187 (Prescription Drug User Fee Act (PFUFA)) FDA funding issues, including issues such as user fees and future appropriations HR 4274 (PREA Authorization Act of 2012, Best Pharmaceuticals for Children Act and Pediatric Research Equity Act of 2003) and related legislation related to issues of pediatric exclusivity S. 2295, H.R. 4384 and related legislation regarding pharmaceutical labeling changes

Client expense: $370,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)

S. 3187, FDA Safety and Innovation Act; H.R. 4274, Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues relating to health disparities, health care reform, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: S. 494 and H.R. 912, Colorectal Cancer Prevention, Early Detection & Treatment Act; H.R. 1213, Repeal mandatory funding provided to states in PPACA to establish American Health Benefit Exchanges; H.R. 1217, Repeal Prevention and Public Health Fund; H.R. 1740 and H.R. 5560, the Quality Cancer Care for Life Act of 2010; H.R.2941 and S.3493; H.R.3974, Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009; H.R.4662, the Lymphedema Diagnosis and Treatment Cost Savings Act of 2010; the implementation of P.L. 111-148, the Patient Proection and Affordable Care Act of 2010; S.1064, the Sun Act; S.965, the Family Act; H.R.2954, Health Equity and Accountability Act of 2011; and H.R.2077, the MLR Repeal Act; H.R.2245 and S.296 Preserving Access to Life-Saving Medications Act, issues related to the reauthorization of the prescription drug user fee, S.3187, the FDA Safety and Innovation Act and the House Companion legislation, and issues relating to the ongoing national shortage of cancer drugs, Amendment relating to S.1813, the Moving Ahead for Progress in the 21st Century Act, and H.R.4274, reauthorization of the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act. Issues relating to global health including S.2515, the Clean Cookstoves Support Act of 2012; H.R.6155 & S.3047, the Palliative Care and Hospice Education & Training Act; and H.R.6157, the Patient Centered Quality of Care Act.

Client expense: $620,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), White House Office

HR 3590 - Patient Protection and Affordable Care Act - implementation of all provisions related to health, coverage, benefits, and Medicaid HR 1852/S958 - Children's Hospital Graduate Medical Education - Acts to reauthorize and establish funding levels for the program 340B - Implementation of 340B drug discount program for orphan drugs provided through children's hospitals HIT - Certification Standards for Meaningful Use - HIT standards and application to children's hospitals and providers H.R. 2245 & S. 296, Preserving Access to Life-Saving Medications Act of 2011 - work to address growing national drug shortages by requiring drug manufacturers to report foreseeable shortages to the Food & Drug Administration (FDA) 6 months in advance. H.R. 2182, Generating Antibiotic Incentives Now (GAIN) Act of 2011 - work to address antibiotic resistance by incentivizing research and development of more-effective antibiotics through, e.g., increased Hatch-Waxman exclusivity and expedited FDA review. S. 606, Creating Hope Act of 2011- work on a bill that encourages development of new treatments for rare and neglected diseases that disproportionately affect children. H.R. 2679 & S. 1440, PREEMIE Reauthorization Act - work on a bill that authorizes programmatic and grant funding for research into the causes of preterm birth and promotes the development of evidence-based standards of care for at-risk pregnancies. H.R. 2795, Fit for Life Act - work on a bill that proposes to increase funding available for obesity prevention and treatment programs through the USDA and HHS. Prescription Drug User Fee Act (no bill number) HR 4274 - Best Pharmaceuticals for Children Act and Pediatric Research Equality Act

Client expense: $900,742 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE

HR 3590 - Patient Protection and Affordable Care Act - implementation of all provisions related to health, coverage, benefits, and Medicaid HR 1852/S958 - Children's Hospital Graduate Medical Education - Acts to reauthorize and establish funding levels for the program 340B - Implementation of 340B drug discount program for orphan drugs provided through children's hospitals HIT - Certification Standards for Meaningful Use - HIT standards and application to children's hospitals and providers H.R. 2245 & S. 296, Preserving Access to Life-Saving Medications Act of 2011 - work to address growing national drug shortages by requiring drug manufacturers to report foreseeable shortages to the Food & Drug Administration (FDA) 6 months in advance. H.R. 2182, Generating Antibiotic Incentives Now (GAIN) Act of 2011 - work to address antibiotic resistance by incentivizing research and development of more-effective antibiotics through, e.g., increased Hatch-Waxman exclusivity and expedited FDA review. S. 606, Creating Hope Act of 2011- work on a bill that encourages development of new treatments for rare and neglected diseases that disproportionately affect children. H.R. 2679 & S. 1440, PREEMIE Reauthorization Act - work on a bill that authorizes programmatic and grant funding for research into the causes of preterm birth and promotes the development of evidence-based standards of care for at-risk pregnancies. H.R. 2795, Fit for Life Act - work on a bill that proposes to increase funding available for obesity prevention and treatment programs through the USDA and HHS. Prescription Drug User Fee Act (no bill number) HR 4274 - Best Pharmaceuticals for Children Act and Pediatric Research Equality Act

Client expense: $900,742 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE

H.R. 4274 BEST Pharmaceuticals for Children Act and Pediatric Research Equity Act; FDA Safety & Innovation Act

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Legislation and issues relating to: Provisions of the Patient Protection & Affordable Care Act (P.L. 111-148); Nurse Education, Expansion, and Development Act; Nursing provisions in potential job creation legislation; Anti-competitive barriers to practice; Negotiated Rulemaking on Designation of Medically Underserved and Health Professional Shortage Areas; Administration review of current regulations; Prevention and Public Health Fund; Definition of essential health benefits; Health information technology and electronic health records; HRSA nurse practitioner national sample survey; Amendments to the Consumer Product Safety Improvement Act; Menu and Nutrition Labeling; Draft legislation to reauthorize the Prescription Drug User Fee Act (PDUFA); Draft legislation on Congressional Budget Office scoring of preventive health services; Draft legislation on voluntary tandem licensing and credentialing for federal telemedicine services; Draft legislation on reauthorization of the National Quality Forum; H.R. 5/S. 218/S. 1099 - Help Efficient, Accessible, Low Cost, Timely Healthcare (HEALTH) Act; H.R. 5 - Protecting Access to Healthcare (PATH) Act; H.R. 451 - Healthcare Truth and Transparency Act of 2011; S. 248/H.R. 844 - Empowering States to Innovate Act; S. 174 - Healthy Lifestyles and Prevention Act; H.R. 10/S. 299/S. 1720/S. 1786 - Regulations From the Executive in Need of Scrutiny (REINS) Act; H.R. 1217 - to repeal the Prevention and Public Health Fund; H.R. 1683/S. 868 - State Flexibility Act; H.R. 2465 - Federal Workers' Compensation Modernization and Improvement Act; S. 261 - Federal Employees' Compensation Reform Act; H.R. 469 - Protecting Student Athletes from Concussions Act; S. 601/H.R. 1127 - Childrens Sports Athletic Equipment Safety Act; Concussion Treatment and Care Tools (ConTACT) Act; S. 54 - Supporting Child Maltreatment Prevention Efforts in Community Health Centers Act; S. 55 - Nursing School Clinics Act; H.R. 157 - Health Care Safety Net Enhancement Act; H.R. 227 - Child Gun Safety and Gun Access Prevention Act; H.R. 338 - Protecting Our Kids' Medicine Act; H.R. 469 - Protecting Student Athletes from Concussions Act; H.R. 576 - Healthy Children Through School Nutrition Education Act; H.R. 713 - Keeping Families Together Act; H.R. 751 - Mental Health in Schools Act; H.R. 1214 - to repeal mandatory funding for school-based health center construction; S. 961 - Reconnecting Youth to Prevent Homelessness Act; S. 1165, Button Cell Battery Safety Act; H.R. 1852/S. 958 - Childrens Hospital GME Support Reauthorization Act; H.R. 115 - CHAMPVA Childrens Protection Act; H.R. 364 - Common Sense Health Reform Americans Actually Want Act; H.R. 614 - Post 9/11 G.I. Bill Dependent Coverage Improvement Act; H.R. 978 - Seniors Identity Protection Act; H.R. 989 - Voluntary State Discount Prescription Drug Plan Act; H.R. 1035/S. 1504 - Medicaid Coverage for Citizens of Freely Associated States Act; H.R. 2029/S. 1131 - Birth Defects Prevention, Risk Reduction, and Awareness Act; H.R. 2758/S. 1463 - Breastfeeding Promotion Act; H.R. 2229 - Student-to-School Nurse Ratio Improvement Act. H.R. 3679 - National Nurse Act; H.R. 4274 - BPCA and PREA Reauthorization Act; S. 2289 - Better Pharmaceuticals and Devices for Children Act; H.R. 5651 - Food and Drug Administration Reform Act; H.R. 5842 - Restoring Access to Medication Act; S. 3187 - FDA Safety and Innovation Act; S. 2474 - Health Equity and Accountability Act; S. 1789 - 21st Century Postal Service Act; S. 847 - Safe Chemicals Act; H.R. 2405/S. 1855 - Pandemic and All-Hazards Preparedness Act (PAHPA); H.R. 2359 - Safe Cosmetics Act; H.R. 6482 - Preventive Health Savings Act; Supplemental Nutrition Assistance Program (SNAP) provisions of H.R. 6083, Federal Agriculture Reform and Risk Management (FARRM) Act, and S.3240, Agriculture Reform, Food, and Jobs Act.

Client expense: Not reported · Firm income: $23,450

Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE, White House Office

Legislation and issues relating to: Provisions of the Patient Protection & Affordable Care Act (P.L. 111-148); Nurse Education, Expansion, and Development Act; Nursing provisions in potential job creation legislation; Anti-competitive barriers to practice; Negotiated Rulemaking on Designation of Medically Underserved and Health Professional Shortage Areas; Administration review of current regulations; Prevention and Public Health Fund; Definition of essential health benefits; Health information technology and electronic health records; HRSA nurse practitioner national sample survey; Draft legislation to reauthorize the Prescription Drug User Fee Act (PDUFA); Draft legislation on Congressional Budget Office scoring of preventive health services; Draft legislation on voluntary tandem licensing and credentialing for federal telemedicine services; Draft legislation on reauthorization of the National Quality Forum; H.R. 5/S. 218/S. 1099 - Help Efficient, Accessible, Low Cost, Timely Healthcare (HEALTH) Act; H.R. 5 - Protecting Access to Healthcare (PATH) Act; H.R. 451 - Healthcare Truth and Transparency Act of 2011; S. 248/H.R. 844 - Empowering States to Innovate Act; S. 174 - Healthy Lifestyles and Prevention Act; H.R. 10/S. 299/S. 1720/S. 1786 - Regulations From the Executive in Need of Scrutiny (REINS) Act; H.R. 1217 - to repeal the Prevention and Public Health Fund; H.R. 1683/S. 868 - State Flexibility Act; H.R. 2465 - Federal Workers' Compensation Modernization and Improvement Act; S. 261 - Federal Employees' Compensation Reform Act; H.R. 469 - Protecting Student Athletes from Concussions Act; S. 601/H.R. 1127 - Childrens Sports Athletic Equipment Safety Act; Concussion Treatment and Care Tools (ConTACT) Act; H.R. 3679 - National Nurse Act; H.R. 4274 - BPCA and PREA Reauthorization Act; S. 2289 - Better Pharmaceuticals and Devices for Children Act; H.R. 5651 - Food and Drug Administration Reform Act; H.R. 5842 - Restoring Access to Medication Act; S. 3187 - FDA Safety and Innovation Act S. 2474 - Health Equity and Accountability Act; S. 1789 - 21st Century Postal Service Act; H.R. 6482 - Preventive Health Savings Act; Supplemental Nutrition Assistance Program (SNAP) provisions of H.R. 6083, Federal Agriculture Reform and Risk Management (FARRM) Act, and S.3240, Agriculture Reform, Food, and Jobs Act.

Client expense: Not reported · Firm income: $23,450

Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE, White House Office

Issues relating to health disparities, health care reform, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: S. 494 and H.R. 912, colorectal Cancer Prevention, Early Detection & Treatment Act; H.R. 1213, repeal mandatory funding provided to states in PPACA to establish American Health Benefit Exchanges; H.R. 1217, repeal Prevention and Public Health Fund; H.R. 1740 and H.R. 5560, the Quality Cancer Care for Life Act of 2010; H.R. 2941 and S. 3493; the Patient Protection and Affordable Care Act of 2010; S. 1064, the Sun Act; S. 965, the Family Act; H.R. 2954, Health Equity and Accountability Act of 2011; and H.R. 2077, the MLR Repeal Act; H.R. 2245 and S. 296 Preserving Access to Life-Saving Medications Act, issues related to the reauthorization of the prescription drug user fee, S. 3187, the FDA Safety and Innovation Act and the House Companion legislation, and issues relating to the ongoing national shortage of cancer drugs, amendment relating to S. 1813, the Moving Ahead for Progress in the 21st Century Act, and H.R. 4274, reauthorization of the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act.

Client expense: $20,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S.2236 - Advancing Breakthrough Therapies for Patients Act of 2012 - provisions related to FDA regulation S.2113 - Transforming the Regulatory Environment to Accelerate Access to Treatments (TREAT) Act - provisions related to accelerated approval and other FDA matters S. 2289 - The Better Pharmaceuticals and Devices for Children Act - "Provisions related to amending the Federal Food, Drug, and Cosmetic Act with respect to pediatric provisions" H.R.4274 - BPCA and PREA Reauthorization Act of 2012 - Provisions related to amending title IV of the Public Health Service Act and title V of the Federal Food, Drug, and Cosmetic Act to permanently extend the provisions of the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act H.R.4156, S.2281 - Expanding and Promoting Expertise in Rare Treatments Act of 2012 - provisions related to strengthening the FDA's ability to seek advice from external experts regarding rare diseases H.R.4132 - FAST Act - provisions related to accelerated approval and other FDA matters H.R.3839 - Drug Shortage Prevention Act of 2012 - provisions related to prescription drug shortages H.R.2674 - 340B Program Improvement Act - provisions related to the 340B program PL 111-148, PL 111-152 - Patient Protection and Affordable Care Act - ACA implementation, Independent Payment Advisory Board (IPAB), comparative effectiveness, health information technology, disease prevention/wellness, sunshine and innovation provisions H.R.2405, S.1855 - Pandemic and All Hazards Preparedness Act - provisions relating to influenza vaccine innovative technologies H.R.4223, S.1002 - Strengthening and Focusing Enforcement to Deter Organized Stealing and Enhance Safety Act (SAFE DOSES) provisions related to supply chain security H.R.1483 - The Drug Safety Enhancement Act of 2011 - provisions related to supply chain security H.R.1930, S.1799 - Access to Appropriate Immunizations for Veterans Act of 2011 - provisions related to extending VA performance measure to include all federally recommended vaccine H.R.3202 - Water Protection and Reinvestment Act - provisions pertaining to pharmaceuticals in the environment H.R.2245, S.296 - Preserving Access to Life-Savings Medicines Act of 2011 - provisions related to drug shortages H.R.2939 - Pharmaceutical Stewardship Act of 2011 - provisions related to drug safety H.R.5651 - Food and Drug Administration Reform Act of 2012 - provisions related to user fee reauthorization and FDA reform S. 3187 - Food and Drug Administration Safety and Innovation Act of 2012 - provisions related to user fee reauthorization and FDA reform H.R.2529, S.1368 - Restoring Access to Medication Act - provisions relating to reimbursement of OTC drugs under flexible spending and health savings accounts S.1584 - Drug Safety and Accountability Act of 2011 - provisions related to drug safety No bill # assigned - Federal Food, Drug, and Cosmetic Act - section related to FDA and regulation of nicotine replacement therapies S.1699 - Prescription Drug Cost Reduction Act - provisions related to 340B and drug rebates H.R.3204 - Guidance Accountability and Transparency Act - provisions to set forth interpretation policy of FDA guidance S.810 - Great Ape Protection and Cost Savings Act of 2011 - provisions related to pre-clinical testing H.R.6190 - Asthma Inhalers Relief Act of 2012 - provisions relating to the removal of Essential-Use Designation for epinephrine S.1752 - Freedom to Breath Act of 2011 - provisions relating to the removal of Essential-Use Designation for epinephrine No bill # assigned - Comparative effectiveness policy issues No bill # assigned - Efforts to amend the National Childhood Vaccine Injury Act of 1986 (26 USC 4132(N)) to include any vaccine against seasonal influenza.

Client expense: $890,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Natl Security Council (NSC), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office

Appropriations for Patient Protection and Affordable Care Act (ACA) Behavioral Health Information Technology Act (S. 539) (HR 6043) State Flexibility Act (HR1683) The BPCA and PREA Reauthorization Act (HR4274) Preserving Access to Life Saving Medication Act (S. 296) (HR2245) Drug Shortage Prevention Act (HR3839) Food and Drug Administration Safety and Innovation Act (S. 3187) (HR 5651) Synthetic Drug Abuse Prevention Act (S. 3190) (HR 1254) Synthetics are Dangerous Act (HR 4205) Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act 2013 (S. 3295) (HR 3070)

Client expense: Not reported · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)

S. 319, Pharmaceutical Market Access and Drug Safety Act - Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 752, Lung Cancer Mortality Reduction Act of 2011 - Lobbied for passage of bill to reduce lung cancer mortality. NO BILL, Health Care Reform Implementation - Lobbied on implementation of provisions in the health care reform bill regarding biosimilars, the Independent Payment Advisory Board and the Annual Fee. S. 296 and H.R. 2245, Preserving Access to Life-Savings Medications Act - Lobbied to improve provisions in the drug shortage legislation. H.R. 1483, Drug Safety Enhancement Act of 2011 - Lobbied to pass meaningful drug safety legislation. S. 3187, the "Food and Drug Administration Safety and Innovation Act - Lobbied for passage of PDUFA legislation. S. 2113, Transforming the Regulatory Environment to Accelerate Access to Treatments - Lobbied to pass meaningful FDA reform legislation. S. 2236, Advancing Breakthrough Therapies for Patients Act of 2012 - Lobbied to pass meaningful FDA reform legislation. H.R. 4274, BCPA and PREA Reauthorization Act of 2012 - Lobbied for permanence of BCPA and PREA. H.R. 3497, MODERN Cures Act of 2011 - Lobbied for incentives for development of pharmacodiagnostics and dormant therapies. H.R. 3737, Unlocking Lifesaving Treatments for Rare-Diseases Act - Lobbied to pass meaningful FDA reform legislation. H.R. 4132, Faster Access to Specialized Treatments Act - Lobbied to pass meaningful FDA reform legislation. Labor, HHS Appropriations. Lobbied for increased access to HIV/AIDS drugs in the AIDS Drug Assistance Program.

Client expense: $520,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE, Treasury, Dept of

P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample reporting provisions; S.3187 FDA Safety and Innovation Act; H.R. 4274 Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; Pharmaceutical Traceability Enhancement Code (Rx TEC) Act; H.R. 5973 FY2013 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (FDA funding); 340B

Client expense: $400,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, White House Office

P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample transparency reporting provisions; S.3187 FDA Safety and Innovation Act (PDUFA V); H.R. 4274 Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; Pharmaceutical Traceability Enhancement Code (Rx TEC) Act; H.R. 5973 FY2013 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (FDA funding); 340B

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE

FDA funding issues, including issues such as user fees and possible future appropriations that are likely to be incorporated into the Prescription Drug User Fee Act (PDUFA) (no bill number yet) H.R. 4274 (PREA Authorization Act of 2012, Best Pharmaceuticals for Children Act and Pediatric Research Equity Act of 2003) - issues related to pediatric exclusivity and related issues to be incorporated into PDUFA legislation

Client expense: $1,110,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)

S. 1440/H.R. 2679 PREEMIE Reauthorization Act H.R. 1852/S. 958 Children's Hospital GME Support Reauthorization Act of 2011 H.R. 2029/S. 1131, Birth Defects Prevention, Risk Reduction and Awareness Act Issues related to maternal and child health within HHS, NIH, HRSA, CDC and FDA S. 2289, Better Pharmaceuticals and Devices for Children Act of 2012 H.R. 4274, BPCA and PREA Reauthorization Act of 2012 S.J. Res 37, A joint resolution to disapprove a rule promulgated by the Administrator of the EPA relating to emission standards for certain steam generating units. H.R. 4628, Interest Rate Reduction Act, Section 3 Repealing Prevention and Public Health Fund Affordable Care Act implementation pertaining to women and children Health care quality issues Prevention and Public Health Fund

Client expense: $70,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE, Treasury, Dept of

S. 1440/H.R. 2679 PREEMIE Reauthorization Act H.R. 1852/S. 958 Children's Hospital GME Support Reauthorization Act of 2011 H.R. 2029/S. 1131, Birth Defects Prevention, Risk Reduction and Awareness Act Issues related to maternal and child health within HHS, NIH, HRSA, CDC and FDA S. 2289, Better Pharmaceuticals and Devices for Children Act of 2012 H.R. 4274, BPCA and PREA Reauthorization Act of 2012 S.J. Res 37, A joint resolution to disapprove a rule promulgated by the Administrator of the EPA relating to emission standards for certain steam generating units. H.R. 4628, Interest Rate Reduction Act, Section 3 Repealing Prevention and Public Health Fund Affordable Care Act implementation pertaining to women and children Health care quality issues Prevention and Public Health Fund

Client expense: $50,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE, Treasury, Dept of

Issues relating to health disparities, health care reform, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: S. 494 and H.R. 912 Colorectal Cancer Prevention, Early Detection & Treatment Act; H.R. 1213, repeal mandatory funding provided to states in PPACA to establish American Health Benefit Exchanges; H.R. 1217, Repeal Prevention and Public Health Fund; H.R. 1740 and H.R. 5560, the quality Cancer Care for Life Act of 2010; H.R. 2941 and S. 3493; H.R. 3974, Viral Hepatatis and Liver Cancer Control and Prevention Act of 2009; H.R. 4662, the Lymphedema Diagnosis and Treatment Cost Savings Act of 2010; S. 1064, The Sun Act; S. 965, the Family Act; H.R. 2954, Health Equity and Accountability Act of 2011; and H.R. 2077, the MLR Repeal Act; H.R. 2245and S.296 Preserving Access to Life-Saving Medications Act, issues related to the reauthorization of the prescription drug user fee, S. 3187, the FDA Safety and Innovation Act and the House Companion legislation, and issues relating to the ongoig the national shortage of cancer drugs. Amendment relating to S. 1813, the Moving Ahead for Progress in the 21st Century Act, and H.R. 4274, reauthorization of the Best Pharmaceutials for Children Act and the Pediatric Research Equity Act.

Client expense: $420,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 5651, S. 3187 (Prescription Drug User Fee Act (PFUFA)) FDA funding issues, including issues such as user fees and future appropriations HR 4274 (PREA Authorization Act of 2012, Best Pharmaceuticals for Children Act and Pediatric Research Equity Act of 2003) and related legislation related to issues of pediatric exclusivity S. 2295, H.R. 4384 and related legislation regarding pharmaceutical labeling changes

Client expense: $360,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)

Issues relating to health disparities, health care reform, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: S. 494 and H.R. 912, Colorectal Cancer Prevention, Early Detection & Treatment Act; H.R. 1213, Repeal mandatory funding provided to states in PPACA to establish American Health Benefit Exchanges; H.R. 1217, Repeal Prevention and Public Health Fund; H.R. 1740 and H.R. 5560, the Quality Cancer Care for Life Act of 2010; H.R. 2941 and S. 3493; H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009; H.R. 4662, the Lymphedema Diagnosis and Treatment Cost Savings Act of 2010; the implementation of P.L. 111-148, the Patient Proection and Affordable Care Act of 2010; S. 1064, the Sun Act; S 965, the Family Act; H.R. 2954, Health Equity and Accountability Act of 2011; and H.R. 2077, the MLR Repeal Act; H.R. 2245 and S. 296 Preserving Access to Life-Saving Medications Act, issues related to the reauthorization of the prescription drug user fee, S.3187, the FDA Safety and Innovation Act and the House Companion legislation, and issues relating to the ongoing national shortage of cancer drugs, Amendment relating to S.1813, the Moving Ahead for Progress in the 21st Century Act, and H.R. 4274, reauthorization of the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act. Issues relating to global health including S. 2515, the Clean Cookstoves Support Act of 2012.

Client expense: $590,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), White House Office

S. 3187, FDA Safety and Innovation Act; H.R. 4274, Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Legislation and issues relating to: Provisions of the Patient Protection & Affordable Care Act (P.L. 111-148); Nurse Education, Expansion, and Development Act; Nursing provisions in potential job creation legislation; Negotiated Rulemaking on Designation of Medically Underserved and Health Professional Shortage Areas; Administration review of current regulations; Prevention and Public Health Fund; Definition of essential health benefits; Health information technology and electronic health records; HRSA nurse practitioner national sample survey; Amendments to the Consumer Product Safety Improvement Act; Menu and Nutrition Labeling; Draft legislation to reauthorize the Prescription Drug User Fee Act (PDUFA); Draft legislation on Congressional Budget Office scoring of preventive health services; Draft legislation on voluntary tandem licensing and credentialing for federal telemedicine services; H.R. 5/S. 218/S. 1099 - Help Efficient, Accessible, Low Cost, Timely Healthcare (HEALTH) Act; H.R. 5 - Protecting Access to Healthcare (PATH) Act; H.R. 451 - Healthcare Truth and Transparency Act of 2011; S. 248/H.R. 844 - Empowering States to Innovate Act; S. 174 - Healthy Lifestyles and Prevention Act; H.R. 10/S. 299/S. 1720/S. 1786 - Regulations From the Executive in Need of Scrutiny (REINS) Act; H.R. 1217 - to repeal the Prevention and Public Health Fund; H.R. 1683/S. 868 - State Flexibility Act; H.R. 2465 - Federal Workers' Compensation Modernization and Improvement Act; S. 261 - Federal Employees' Compensation Reform Act; H.R. 469 - Protecting Student Athletes from Concussions Act; S. 601/H.R. 1127 - Childrens Sports Athletic Equipment Safety Act; Concussion Treatment and Care Tools (ConTACT) Act; S. 54 - Supporting Child Maltreatment Prevention Efforts in Community Health Centers Act; S. 55 - Nursing School Clinics Act; H.R. 157 - Health Care Safety Net Enhancement Act; H.R. 227 - Child Gun Safety and Gun Access Prevention Act; H.R. 338 - Protecting Our Kids' Medicine Act; H.R. 469 - Protecting Student Athletes from Concussions Act; H.R. 576 - Healthy Children Through School Nutrition Education Act; H.R. 713 - Keeping Families Together Act; H.R. 751 - Mental Health in Schools Act; H.R. 1214 - to repeal mandatory funding for school-based health center construction; S. 961 - Reconnecting Youth to Prevent Homelessness Act; S. 1165, Button Cell Battery Safety Act. H.R. 1852/S. 958 - Childrens Hospital GME Support Reauthorization Act; H.R. 115 - CHAMPVA Childrens Protection Act; H.R. 364 - Common Sense Health Reform Americans Actually Want Act; H.R. 614 - Post 9/11 G.I. Bill Dependent Coverage Improvement Act; H.R. 978 - Seniors Identity Protection Act; H.R. 989 - Voluntary State Discount Prescription Drug Plan Act; H.R. 1035/S. 1504 - Medicaid Coverage for Citizens of Freely Associated States Act; H.R. 2029/S. 1131 - Birth Defects Prevention, Risk Reduction, and Awareness Act; H.R. 2758/S. 1463 - Breastfeeding Promotion Act; H.R. 2229 - Student-to-School Nurse Ratio Improvement Act. H.R. 3679 - National Nurse Act; H.R. 4274 - BPCA and PREA Reauthorization Act; S. 2289 - Better Pharmaceuticals and Devices for Children Act; H.R. 5651 - Food and Drug Administration Reform Act; H.R. 5842 - Restoring Access to Medication Act; S. 3187 - FDA Safety and Innovation Act S. 2474 - Health Equity and Accountability Act; S. 1789 - 21st Century Postal Service Act.

Client expense: Not reported · Firm income: $23,450

Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE, White House Office

Legislation and issues relating to: Provisions of the Patient Protection & Affordable Care Act (P.L. 111-148); Nurse Education, Expansion, and Development Act; Nursing provisions in potential job creation legislation; Negotiated Rulemaking on Designation of Medically Underserved and Health Professional Shortage Areas; Administration review of current regulations; Prevention and Public Health Fund; Definition of essential health benefits; Health information technology and electronic health records; HRSA nurse practitioner national sample survey; Draft legislation to reauthorize the Prescription Drug User Fee Act (PDUFA); Draft legislation on Congressional Budget Office scoring of preventive health services; Draft legislation on voluntary tandem licensing and credentialing for federal telemedicine services; H.R. 5/S. 218/S. 1099 - Help Efficient, Accessible, Low Cost, Timely Healthcare (HEALTH) Act; H.R. 5 - Protecting Access to Healthcare (PATH) Act; H.R. 451 - Healthcare Truth and Transparency Act of 2011; S. 248/H.R. 844 - Empowering States to Innovate Act; S. 174 - Healthy Lifestyles and Prevention Act; H.R. 10/S. 299/S. 1720/S. 1786 - Regulations From the Executive in Need of Scrutiny (REINS) Act; H.R. 1217 - to repeal the Prevention and Public Health Fund; H.R. 1683/S. 868 - State Flexibility Act; H.R. 2465 - Federal Workers' Compensation Modernization and Improvement Act; S. 261 - Federal Employees' Compensation Reform Act; H.R. 469 - Protecting Student Athletes from Concussions Act; S. 601/H.R. 1127 - Childrens Sports Athletic Equipment Safety Act; Concussion Treatment and Care Tools (ConTACT) Act; H.R. 3679 - National Nurse Act; H.R. 4274 - BPCA and PREA Reauthorization Act; S. 2289 - Better Pharmaceuticals and Devices for Children Act; H.R. 5651 - Food and Drug Administration Reform Act; H.R. 5842 - Restoring Access to Medication Act; S. 3187 - FDA Safety and Innovation Act S. 2474 - Health Equity and Accountability Act; S. 1789 - 21st Century Postal Service Act.

Client expense: Not reported · Firm income: $23,450

Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE, White House Office

HR 2/S 192, Repealing the Job-Killing Health Care Law Act HR 5/S 218, Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act of 2011 H.R. 4274, the Better Pharmaceuticals for Children ACT and Pediatric Research Reauthorization Act of 2012 Draft, Senate HELP, drug shortage legislation and Prescription Drug User Fee Act (PDUFA) reauthorization S. 3187, Food and Drug Administration Safety and Innovation Act of 2012 H. R. 2245, S. 296, Preserving Access to Life-Saving Medications Act of 2011 S.1584 , Drug Safety and Accountability Act of 2011 HR 439/S 73, State Leadership in Health Care Act H.R.451, Healthcare Truth and Transparency Act of 2011 H.R.751, Mental Health in Schools Act of 2011 H.R. 831/S 483, To amend title XVIII of the Social Security Act to provide for treatment of clinical psychologists as physicians for purposes of furnishing clinical psychologist services under the Medicare Program S.483, Medicare Mental Health Access Act S.37, Autonomy for Psychologists and Social Workers Act of 2011 S.40, Graduate Psychology Education Act of 2011 S.43, Psychologists in the Service of the Public Act of 2011 S.539, Behavioral Health Information Technology Act of 2011 S 248/ HR 844, Empowering States to Innovate Act S. 525, Positive Aging Act of 2011 S 650/HR 1184, Health Care Waiver Transparency Act S. 374, Medicare Mental Health Inpatient Equity Act S. 1627, Resident Physician Shortage Reduction Act of 2011, A bill to amend title XVIII of the Social Security Act to provide for the distribution of additional residency positions, and for other purposes. HR 5/S 218, Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act of 2011 H Res 92, Providing for consideration of the bill (H.R. 1) making appropriations for the Department of Defense and the other departments and agencies of the Government for the fiscal year ending September 30, 2011, and for other purposes, and waiving a requirement of clause 6(a) of rule XIII with respect to consideration of certain resolutions reported from the Committee on Rules. S. 1542, H.R. 2883, Child and Family Services Improvement and Innovation Act S. 1925, H.R. 4970 Violence against Women Act Reauthorization Act H.R. 6043, the Behavioral Health Information Technology Act of 2012 H.R. 5989, the Excellence in Mental Health Act of 2012 H.R. 5996, the Mental Health First Aid Higher Education Act of 2012 H.R. 5707, the Medicare Physician Payment Innovation Act of 2012 Nationwide Health Information Network: Conditions for Trusted Exchange (HHS-OS-2012-0006) HHS Bulletin on Federally-Facilitated Exchanges

Client expense: $277,532 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Indian Health Service, Office of Management & Budget (OMB), SENATE

HR 3590 - Patient Protection and Affordable Care Act - implementation of all provisions related to health, coverage, benefits, and Medicaid HR 1852/S958 - Children's Hospital Graduate Medical Education - Acts to reauthorize and establish funding levels for the program 340B - Implementation of 340B drug discount program for orphan drugs provided through children's hospitals HIT - Certification Standards for Meaningful Use - HIT standards and application to children's hospitals and providers H.R. 2245 & S. 296, Preserving Access to Life-Saving Medications Act of 2011 - work to address growing national drug shortages by requiring drug manufacturers to report foreseeable shortages to the Food & Drug Administration (FDA) 6 months in advance. H.R. 2182, Generating Antibiotic Incentives Now (GAIN) Act of 2011 - work to address antibiotic resistance by incentivizing research and development of more-effective antibiotics through, e.g., increased Hatch-Waxman exclusivity and expedited FDA review. S. 606, Creating Hope Act of 2011- work on a bill that encourages development of new treatments for rare and neglected diseases that disproportionately affect children. H.R. 2679 & S. 1440, PREEMIE Reauthorization Act - work on a bill that authorizes programmatic and grant funding for research into the causes of preterm birth and promotes the development of evidence-based standards of care for at-risk pregnancies. H.R. 2795, Fit for Life Act - work on a bill that proposes to increase funding available for obesity prevention and treatment programs through the USDA and HHS. Prescription Drug User Fee Act (no bill number) HR 4274 - Best Pharmaceuticals for Children Act and Pediatric Research Equality Act

Client expense: $689,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE

S. 2236 - Advancing Breakthrough Therapies for Patients Act of 2012 - provisions related to FDA regulation S. 2113 - Transforming the Regulatory Environment to Accelerate Access to Treatments (TREAT) Act - provisions related to accelerated approval and other FDA matters S. 2289 - The Better Pharmaceuticals and Devices for Children Act - "Provisions related to amending the Federal Food, Drug, and Cosmetic Act with respect to pediatric provisions" H.R. 4274 - BPCA and PREA Reauthorization Act of 2012 - Provisions related to amending title IV of the Public Health Service Act and title V of the Federal Food, Drug, and Cosmetic Act to permanently extend the provisions of the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act H.R. 4156, S. 2281- Expanding and Promoting Expertise in Rare Treatments Act of 2012 - provisions related to strengthening the FDA's ability to seek advice from external experts regarding rare diseases H.R. 3214 - Food and Drug Administration Mission Reform Act of 2011 - provisions to revise the mission of the Food and Drug Administration H.R. 4132 - FAST Act - provisions related to accelerated approval and other FDA matters H.R. 3839 - Drug Shortage Prevention Act of 2012 - provisions related to prescription drug shortages H.R. 2674 - 340B Program Improvement Act - provisions related to the 340B program PL 111-148, PL 111-152 - Patient Protection and Affordable Care Act - ACA implementation, Independent Payment Advisory Board (IPAB), comparative effectiveness, health information technology, disease prevention/wellness, sunshine and innovation provisions H.R. 2405, S. 1855 - Pandemic and All Hazards Preparedness Act - provisions relating to influenza vaccine innovative technologies H.R. 4223, S. 1002 - Strengthening and Focusing Enforcement to Deter Organized Stealing and Enhance Safety Act (SAFE DOSES) - provisions related to supply chain security H.R. 1483 - The Drug Safety Enhancement Act of 2011- provisions related to supply chain security H.R. 1930, S. 1799 - Access to Appropriate Immunizations for Veterans Act of 2011- provisions related to extending VA performance measure to include all federally recommended vaccine H.R. 3202 - Water Protection and Reinvestment Act - provisions pertaining to pharmaceuticals in the environment S. 3397 - Secure and Responsible Drug Disposal Act - provisions related to safe drug disposal S. 319 - Pharmaceutical Market Access and Drug Safety Act of 2011 - provisions related to drug importation H.R. 2245, S. 296 - Preserving Access to Life-Savings Medicines Act of 2011 - provisions related to drug shortages H.R. 2939 - Pharmaceutical Stewardship Act of 2011-provisions related to drug safety H.R. 5651 - Food and Rug Administration Reform Act of 2012-provisions related to user fee reauthorization and FDA reform S. 3187 - Food and Drug Administration Safety and Innovation Act of 2012 - provisions related to user fee reauthorization and FDA reform H.R. 2529, S. 1368 - Restoring Access to Medication Act - provisions relating to reimbursement of OTC drugs under flexible spending and health savings accounts S. 1584 - Drug Safety and Accountability Act of 2011 - provisions related to drug safety No bill # assigned - Federal Food, Drug, and Cosmetic Act - section related to FDA and regulation of nicotine replacement therapies S. 1699 - Prescription Drug Cost Reduction Act - provisions related to 340B and drug rebates H.R. 3204 - Guidance Accountability and Transparency Act - provisions to set forth interpretation policy of FDA guidance No bill # assigned - USAID Child Survival Call to Action S. 1752 - Freedom to Breathe Act of 2011 -provisions relating to the removal of Essential-Use Designation for epinephrine. No bill # assigned -Efforts to amend the National Childhood Vaccine Injury Act of 1986 (26 USC 4132(N)) to include any vaccine against seasonal influenza.

Client expense: $1,220,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Natl Security Council (NSC), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office

Better Pharmaceuticals and Devices for Children Act S. 2289 Food and Drug Safety and Innovation Act S.3187 Pediatric Medical Device Safety and Improvement Act HR 3975 HR 4274 Patient Access to Medical Innovation Act S 1865

Client expense: $23,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Appropriations for Patient Protection and Affordable Care Act (ACA Behavioral Health Information Technology Act (HR2005) State Flexibility Act (HR1683) The BPCA and PREA Reauthorization Act (HR4274) Preserving Access to Life Saving Medications Act (S. 296) (HR2245) Drug Shortage Prevention Act (HR3839) Food and Drug Administration Safety and Innovation Act (S. 3187) (HR 5651) Synthetic Drug Abuse Prevention Act (S. 3190) (HR 1254) Synthetics are Dangerous Act (HR 4205) Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act 2013 (S. 3295) (HR 3070)

Client expense: Not reported · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)

S. 319, Pharmaceutical Market Access and Drug Safety Act - Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 752, Lung Cancer Mortality Reduction Act of 2011 - Lobbied for passage of bill to reduce lung cancer mortality. NO BILL, Health Care Reform Implementation - Lobbied on implementation of provisions in the health care reform bill regarding biosimilars, the Independent Payment Advisory Board and the Annual Fee. S. 296 and H.R. 2245, Preserving Access to Life-Savings Medications Act - Lobbied to improve provisions in the drug shortage legislation. H.R. 1483, Drug Safety Enhancement Act of 2011 - Lobbied to pass meaningful drug safety legislation. NO BILL, Reauthorization of the Prescription Drug User Fee Act - Lobbied for passage of clean PDUFA legislation. Labor, HHS Appropriations - Lobbied for increased access to HIV/AIDS drugs in the AIDS Drug Assistance Program. S. 2113, Transforming the Regulatory Environment to Accelerate Access to Treatments - Lobbied to pass meaningful FDA reform legislation. S. 2236, Advancing Breakthrough Therapies for Patients Act of 2012 - Lobbied to pass meaningful FDA reform legislation. H.R. 4274, BCPA and PREA Reauthorization Act of 2012 - Lobbied for permanence of BCPA and PREA. H.R. 3497, MODERN Cures Act of 2011 - Lobbied for incentives for development of pharmacodiagnostics and dormant therapies. H.R. 3737, Unlocking Lifesaving Treatments for Rare-Diseases Act - Lobbied to pass meaningful FDA reform legislation. H.R. 4132, Faster Access to Specialized Treatments Act - Lobbied to pass meaningful FDA reform legislation.

Client expense: $820,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE, Treasury, Dept of

S. 319, Pharmaceutical Market Access and Drug Safety Act - Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 752, Lung Cancer Mortality Reduction Act of 2011 - Lobbied for passage of bill to reduce lung cancer mortality. NO BILL, Health Care Reform Implementation - Lobbied on implementation of provisions in the health care reform bill regarding biosimilars, the Independent Payment Advisory Board and the Annual Fee. S. 296 and H.R. 2245, Preserving Access to Life-Savings Medications Act - Lobbied to improve provisions in the drug shortage legislation. H.R. 1483, Drug Safety Enhancement Act of 2011 - Lobbied to pass meaningful drug safety legislation. S. 3187, the "Food and Drug Administration Safety and Innovation Act - Lobbied for passage of PDUFA legislation. Labor, HHS Appropriations - Lobbied for increased access to HIV/AIDS drugs in the AIDS Drug Assistance Program. S. 2113, Transforming the Regulatory Environment to Accelerate Access to Treatments - Lobbied to pass meaningful FDA reform legislation. S. 2236, Advancing Breakthrough Therapies for Patients Act of 2012 - Lobbied to pass meaningful FDA reform legislation. H.R. 4274, BCPA and PREA Reauthorization Act of 2012 - Lobbied for permanence of BCPA and PREA. H.R. 3497, MODERN Cures Act of 2011 - Lobbied for incentives for development of pharmacodiagnostics and dormant therapies. H.R. 3737, Unlocking Lifesaving Treatments for Rare-Diseases Act - Lobbied to pass meaningful FDA reform legislation. H.R. 4132, Faster Access to Specialized Treatments Act - Lobbied to pass meaningful FDA reform legislation.

Client expense: $660,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE, Treasury, Dept of

S. 319, Pharmaceutical Market Access and Drug Safety Act - Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 752, Lung Cancer Mortality Reduction Act of 2011 - Lobbied for passage of bill to reduce lung cancer mortality. NO BILL, Health Care Reform Implementation - Lobbied on implementation of provisions in the health care reform bill regarding biosimilars, the Independent Payment Advisory Board and the Annual Fee. S. 296 and H.R. 2245, Preserving Access to Life-Savings Medications Act - Lobbied to improve provisions in the drug shortage legislation. H.R. 1483, Drug Safety Enhancement Act of 2011 - Lobbied to pass meaningful drug safety legislation. NO BILL, Reauthorization of the Prescription Drug User Fee Act - Lobbied for passage of clean PDUFA legislation. Labor, HHS Appropriations - Lobbied for increased access to HIV/AIDS drugs in the AIDS Drug Assistance Program. S. 2113, Transforming the Regulatory Environment to Accelerate Access to Treatments - Lobbied to pass meaningful FDA reform legislation. S. 2236, Advancing Breakthrough Therapies for Patients Act of 2012 - Lobbied to pass meaningful FDA reform legislation. H.R. 4274, BCPA and PREA Reauthorization Act of 2012 - Lobbied for permanence of BCPA and PREA. H.R. 3497, MODERN Cures Act of 2011 - Lobbied for incentives for development of pharmacodiagnostics and dormant therapies. H.R. 3737, Unlocking Lifesaving Treatments for Rare-Diseases Act - Lobbied to pass meaningful FDA reform legislation. H.R. 4132, Faster Access to Specialized Treatments Act - Lobbied to pass meaningful FDA reform legislation.

Client expense: $820,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE, Treasury, Dept of

H.R. 4274 BEST Pharmaceuticals for Children Act and Pediatric Research Equity Act; FDA Safety and Innovation Act

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample reporting provisions; S.3187 FDA Safety and Innovation Act (PDUFA V); H.R. 4274 Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; Pharmaceutical Traceability Enhancement Code (Rx TEC) Act; H.R. 5973 FY2013 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (FDA funding); 340B

Client expense: $900,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, White House Office

FDA funding issues, including issues such as user fees and possible future appropriations that are likely to be incorporated into the Prescription Drug User Fee Act (PDUFA) (no bill number yet) H.R. 4274 (PREA Authorization Act of 2012, Best Pharmaceuticals for Children Act and Pediatric Research Equity Act of 2003) - issues related to pediatric exclusivity and related issues to be incorporated into PDUFA legislation

Client expense: $1,190,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)

Legislation and issues relating to: Provisions of the Patient Protection & Affordable Care Act (P.L. 111-148); Nurse Education, Expansion, and Development Act; Nursing provisions in potential job creation legislation; Negotiated Rulemaking on Designation of Medically Underserved and Health Professional Shortage Areas; Administration review of current regulations; Health information technology and electronic health records; Repeal of Medicaid maintenance of effort requirements; HRSA nurse practitioner national sample survey; Amendments to the Consumer Product Safety Improvement Act; Menu and Nutrition Labeling; Draft legislation to reauthorize the Prescription Drug User Fee Act (PDUFA); H.R. 5/S. 218/S. 1099 - Help Efficient, Accessible, Low Cost, Timely Healthcare (HEALTH) Act; H.R. 5 - Protecting Access to Healthcare (PATH) Act; H.R. 451 - Healthcare Truth and Transparency Act of 2011; S. 248/H.R. 844 - Empowering States to Innovate Act; S. 174 - Healthy Lifestyles and Prevention Act; H.R. 10/S. 299/S. 1720/S. 1786 - Regulations From the Executive in Need of Scrutiny (REINS) Act; H.R. 1217 - to repeal the Prevention and Public Health Fund; H.R. 1683/S. 868 - State Flexibility Act; H.R. 2465 - Federal Workers' Compensation Modernization and Improvement Act; S. 261 - Federal Employees' Compensation Reform Act; H.R. 469 - Protecting Student Athletes from Concussions Act; S. 601/H.R. 1127 - Childrens Sports Athletic Equipment Safety Act; Concussion Treatment and Care Tools (ConTACT) Act; H.R. 4160 - State Health Flexibility Act; H.R. 3679 - National Nurse Act; H.R. 4274 - BPCA and PREA Reauthorization Act; S. 54 - Supporting Child Maltreatment Prevention Efforts in Community Health Centers Act; S. 55 - Nursing School Clinics Act; H.R. 157 - Health Care Safety Net Enhancement Act; H.R. 227 - Child Gun Safety and Gun Access Prevention Act; H.R. 338 - Protecting Our Kids' Medicine Act; H.R. 469 - Protecting Student Athletes from Concussions Act; H.R. 576 - Healthy Children Through School Nutrition Education Act; H.R. 713 - Keeping Families Together Act; H.R. 751 - Mental Health in Schools Act; H.R. 1214 - to repeal mandatory funding for school-based health center construction; S. 961 - Reconnecting Youth to Prevent Homelessness Act; S. 1165, Button Cell Battery Safety Act; H.R. 1852/S. 958 - Childrens Hospital GME Support Reauthorization Act; H.R. 115 - CHAMPVA Childrens Protection Act; H.R. 364 - Common Sense Health Reform Americans Actually Want Act; H.R. 614 - Post 9/11 G.I. Bill Dependent Coverage Improvement Act; H.R. 978 - Seniors Identity Protection Act; H.R. 989 - Voluntary State Discount Prescription Drug Plan Act; H.R. 1035/S. 1504 - Medicaid Coverage for Citizens of Freely Associated States Act; H.R. 2029/S. 1131 - Birth Defects Prevention, Risk Reduction, and Awareness Act; H.R. 2758/S. 1463 - Breastfeeding Promotion Act; H.R. 2229 - Student-to-School Nurse Ratio Improvement Act.

Client expense: Not reported · Firm income: $23,450

Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE, White House Office

Legislation and issues relating to: Provisions of the Patient Protection & Affordable Care Act (P.L. 111-148); Nurse Education, Expansion, and Development Act; Nursing provisions in potential job creation legislation; Negotiated Rulemaking on Designation of Medically Underserved and Health Professional Shortage Areas; Administration review of current regulations; Health information technology and electronic health records; Repeal of Medicaid maintenance of effort requirements; HRSA nurse practitioner national sample survey; State of Florida Section 1115 Medicaid waiver application on managed medical assistance program; Draft legislation to reauthorize the Prescription Drug User Fee Act (PDUFA); H.R. 5/S. 218/S. 1099 - Help Efficient, Accessible, Low Cost, Timely Healthcare (HEALTH) Act; H.R. 5 - Protecting Access to Healthcare (PATH) Act; H.R. 451 - Healthcare Truth and Transparency Act of 2011; S. 248/H.R. 844 - Empowering States to Innovate Act; S. 174 - Healthy Lifestyles and Prevention Act; H.R. 10/S. 299/S. 1720/S. 1786 - Regulations From the Executive in Need of Scrutiny (REINS) Act; H.R. 1217 - to repeal the Prevention and Public Health Fund; H.R. 1683/S. 868 - State Flexibility Act; H.R. 2465 - Federal Workers' Compensation Modernization and Improvement Act; S. 261 - Federal Employees' Compensation Reform Act; H.R. 469 - Protecting Student Athletes from Concussions Act; S. 601/H.R. 1127 - Childrens Sports Athletic Equipment Safety Act; Concussion Treatment and Care Tools (ConTACT) Act; H.R. 4160 - State Health Flexibility Act; H.R. 3679 - National Nurse Act; H.R. 4274 - BPCA and PREA Reauthorization Act.

Client expense: Not reported · Firm income: $23,450

Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE, White House Office

HR 2/S 192, Repealing the Job-Killing Health Care Law Act HR 5/S 218, Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act of 2011 HR 439/S 73, State Leadership in Health Care Act H.R.451, Healthcare Truth and Transparency Act of 2011 H.R.751, Mental Health in Schools Act of 2011 H.R. 831/S 483, To amend title XVIII of the Social Security Act to provide for treatment of clinical psychologists as physicians for purposes of furnishing clinical psychologist services under the Medicare Program S.483, Medicare Mental Health Access Act S.37, Autonomy for Psychologists and Social Workers Act of 2011 S.40, Graduate Psychology Education Act of 2011 S.43, Psychologists in the Service of the Public Act of 2011 S.539, Behavioral Health Information Technology Act of 2011 S 248 / HR 844, Empowering States to Innovate Act S. 525, Positive Aging Act of 2011 S 650/HR 1184, Health Care Waiver Transparency Act S. 374, Medicare Mental Health Inpatient Equity Act S. 1627, Resident Physician Shortage Reduction Act of 2011, A bill to amend title XVIII of the Social Security Act to provide for the distribution of additional residency positions, and for other purposes. HR 5/S 218, Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act of 2011 H Res 92, Providing for consideration of the bill (H.R. 1) making appropriations for the Department of Defense and the other departments and agencies of the Government for the fiscal year ending September 30, 2011, and for other purposes, and waiving a requirement of clause 6(a) of rule XIII with respect to consideration of certain resolutions reported from the Committee on Rules. S. 1542, H.R. 2883, Child and Family Services Improvement and Innovation Act HR 4274, the Better Pharmaceuticals for Children ACT and Pediatric Research Reauthorization Act of 2012 Draft, Senate HELP, drug storage legislation and Prescription Drug User Fee Act (PDUFA) reauthorization HR 2245/S 296 Prserving Access to Life-Saving Medications Act of 2011 S. 1584, Drug safety and Accountablity Act of 2011 HR 3765, Temporary Payroll Tax Cut Continuation Act of 2011 HR 3630, Temporary Payroll Tax Cut Continuation Act of 2011 S. 1925 Violence against Women Act Reauthorization HHS Secretary's Bulletin on Essential Health Benefits Final Rule on Medicare Part B Physician Fee Schedules for CY 2012 The use of restraint and seculsion in psychiatric residential treatment facilities providing services to persons under 21 years of age (CMS-2012-0005-0001) Medicare Program; Payment Policies Under the Physician Fee Schedule, Five-Year Review of Work Relative Value Units, Clinical Laboratory Fee Schedule: Signature on Requisition, and Other Revisions to Part B for CY 2012 [CMS1524FC and CMS1436F]

Client expense: $135,786 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Indian Health Service, Office of Management & Budget (OMB), SENATE